2024 Q1 Form 10-Q Financial Statement

#000143774924029935 Filed on September 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q1
Revenue $1.476M $589.0K $711.0K
YoY Change 107.59% -83.57% -55.53%
Cost Of Revenue $640.0K $880.0K $359.0K
YoY Change 78.27% -53.32% -61.48%
Gross Profit $836.0K -$291.0K $352.0K
YoY Change 137.5% -117.12% -47.23%
Gross Profit Margin 56.64% -49.41% 49.51%
Selling, General & Admin $4.220M $5.757M $3.540M
YoY Change 19.21% 29.84% -23.14%
% of Gross Profit 504.78% 1005.68%
Research & Development $755.0K $584.0K $1.072M
YoY Change -29.57% -32.72% -28.29%
% of Gross Profit 90.31% 304.55%
Depreciation & Amortization $223.0K $143.0K $200.0K
YoY Change 11.5% -23.94% 9.29%
% of Gross Profit 26.67% 56.82%
Operating Expenses $4.975M $6.341M $4.612M
YoY Change 7.87% 19.6% -24.41%
Operating Profit -$4.139M -$6.632M -$4.260M
YoY Change -2.84% 84.12% -21.6%
Interest Expense $78.00K -$38.00K $236.0K
YoY Change -66.95% -337.5% 11700.0%
% of Operating Profit
Other Income/Expense, Net $4.256M -$11.73M $232.0K
YoY Change 1734.48% -23101.96% 11500.0%
Pretax Income $117.0K -$18.40M -$4.028M
YoY Change -102.9% 420.54% -25.85%
Income Tax
% Of Pretax Income
Net Earnings $117.0K -$18.79M -$4.028M
YoY Change -102.9% 431.63% -25.85%
Net Earnings / Revenue 7.93% -3190.66% -566.53%
Basic Earnings Per Share $0.00 -$0.10
Diluted Earnings Per Share $0.00 -$0.43 -$0.10
COMMON SHARES
Basic Shares Outstanding 44.16M 44.21M 41.26M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.179M $11.46M $16.00M
YoY Change -48.89% -40.58% -46.6%
Cash & Equivalents $3.179M $3.955M $9.503M
Short-Term Investments $5.000M $7.500M $6.500M
Other Short-Term Assets $825.0K $953.0K $858.0K
YoY Change -3.85% 22.97% 16.73%
Inventory $6.366M $5.794M $5.626M
Prepaid Expenses
Receivables $2.347M $3.025M $1.151M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.72M $21.23M $23.64M
YoY Change -25.05% -20.97% -35.79%
LONG-TERM ASSETS
Property, Plant & Equipment $408.0K $509.0K $655.0K
YoY Change -37.71% -32.85% -30.61%
Goodwill $1.610M $1.610M
YoY Change
Intangibles $2.608M $2.648M $2.618M
YoY Change -0.38% 3.08% 32.16%
Long-Term Investments
YoY Change
Other Assets $244.0K $251.0K $70.00K
YoY Change 248.57% 151.0% 536.36%
Total Long-Term Assets $7.055M $7.274M $3.602M
YoY Change 95.86% 95.96% 9.22%
TOTAL ASSETS
Total Short-Term Assets $17.72M $21.23M $23.64M
Total Long-Term Assets $7.055M $7.274M $3.602M
Total Assets $24.77M $28.50M $27.24M
YoY Change -9.06% -6.77% -32.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.092M $1.110M $1.376M
YoY Change -20.64% -21.78% -20.32%
Accrued Expenses $835.0K $692.0K $1.736M
YoY Change -51.9% -52.7% 111.97%
Deferred Revenue $363.0K $407.0K $169.0K
YoY Change 114.79% 145.18% 39.67%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.45M $23.53M $3.393M
YoY Change 443.85% 645.56% 22.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.836M $1.808M $286.0K
YoY Change 541.96% 402.22% -34.4%
Total Long-Term Liabilities $1.836M $1.808M $286.0K
YoY Change 541.96% 402.22% -34.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.45M $23.53M $3.393M
Total Long-Term Liabilities $1.836M $1.808M $286.0K
Total Liabilities $20.29M $25.34M $3.679M
YoY Change 451.48% 620.65% 15.0%
SHAREHOLDERS EQUITY
Retained Earnings -$98.06M -$97.99M -$71.40M
YoY Change 37.33% 45.43% 29.38%
Common Stock $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.483M $3.163M $23.56M
YoY Change
Total Liabilities & Shareholders Equity $24.77M $28.50M $27.24M
YoY Change -9.06% -6.77% -32.09%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income $117.0K -$18.79M -$4.028M
YoY Change -102.9% 431.63% -25.85%
Depreciation, Depletion And Amortization $223.0K $143.0K $200.0K
YoY Change 11.5% -23.94% 9.29%
Cash From Operating Activities -$3.724M -$3.783M -$3.067M
YoY Change 21.42% 6.06% -36.76%
INVESTING ACTIVITIES
Capital Expenditures $14.00K $153.0K $15.00K
YoY Change -6.67% -80.75% -81.48%
Acquisitions
YoY Change
Other Investing Activities $2.500M $2.561M $7.386M
YoY Change -66.15% -56.33% 47.66%
Cash From Investing Activities $2.420M $2.408M $7.240M
YoY Change -66.57% -52.5% 49.22%
FINANCING ACTIVITIES
Cash Dividend Paid $60.00K $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $528.0K 400.0K $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$3.724M -3.783M -$3.067M
Cash From Investing Activities $2.420M 2.408M $7.240M
Cash From Financing Activities $528.0K 400.0K $0.00
Net Change In Cash -$776.0K -975.0K $4.173M
YoY Change -118.6% -164.91% 5319.48%
FREE CASH FLOW
Cash From Operating Activities -$3.724M -$3.783M -$3.067M
Capital Expenditures $14.00K $153.0K $15.00K
Free Cash Flow -$3.738M -$3.936M -$3.082M
YoY Change 21.28% -9.77% -37.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4028000 usd
CY2023Q1 wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 usd
CY2024Q1 us-gaap Other Operating Income
OtherOperatingIncome
149000 usd
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001702924
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-0 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2024Q1 wrap Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 pure
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
95000 usd
CY2024Q1 us-gaap Revenues
Revenues
1476000 usd
CY2023Q1 us-gaap Revenues
Revenues
711000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
640000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
359000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
836000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
352000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4220000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3540000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
755000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1072000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4975000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4612000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4139000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4260000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
78000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
236000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4179000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4256000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
232000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
189000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-72000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4028000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44155391
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41415808
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-72000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4028000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27055000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
628000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-94000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23561000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3163000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
588000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
675000 usd
CY2024Q1 us-gaap Dividends
Dividends
60000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2024Q1 wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
117000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4483000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4028000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
223000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
675000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
628000 usd
CY2024Q1 wrap Product Warranty Expense Income
ProductWarrantyExpenseIncome
21000 usd
CY2023Q1 wrap Product Warranty Expense Income
ProductWarrantyExpenseIncome
-33000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4179000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2024Q1 wrap Noncash Lease Expense
NoncashLeaseExpense
71000 usd
CY2023Q1 wrap Noncash Lease Expense
NoncashLeaseExpense
26000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-8000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
12000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-683000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1687000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
584000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1652000 usd
CY2024Q1 wrap Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-129000 usd
CY2023Q1 wrap Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
83000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-19000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-42000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
39000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-26000 usd
CY2024Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
982000 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-1000 usd
CY2024Q1 wrap Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
164000 usd
CY2023Q1 wrap Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
306000 usd
CY2024Q1 wrap Increase Decrease In Warranty Settlement
IncreaseDecreaseInWarrantySettlement
-42000 usd
CY2023Q1 wrap Increase Decrease In Warranty Settlement
IncreaseDecreaseInWarrantySettlement
-1000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3724000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3067000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2645000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
2500000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
10000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
-0 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
-31000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2420000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7240000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
588000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
60000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
528000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-776000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4173000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3955000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5330000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3179000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9503000 usd
CY2023Q1 wrap Change In Unrealized Gain On Short Term Investments
ChangeInUnrealizedGainOnShortTermInvestments
-94000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
189000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2024Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
129000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense, valuation of warrants, and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5476219
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5127830
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
491000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4084000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3521000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2759000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2738000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
477000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
465000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
6366000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5794000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1930000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1915000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1522000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1406000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
408000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
509000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
116000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
118000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3099000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3033000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
912000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
806000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2187000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2227000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
421000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
421000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2608000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2648000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
82000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
320000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
422000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
335000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
185000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
185000 usd
CY2024Q1 wrap Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
740000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2187000 usd
CY2024Q1 wrap Accrued Patent And Legal Costs
AccruedPatentAndLegalCosts
120000 usd
CY2023Q4 wrap Accrued Patent And Legal Costs
AccruedPatentAndLegalCosts
21000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
295000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
325000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
51000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
72000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
369000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
274000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
835000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
692000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
72000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
125000 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
42000 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1000 usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
21000 usd
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-33000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
51000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
91000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
71000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
249000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
49000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
619000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1708000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2327000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
372000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
567000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
507000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
522000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
538000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1273000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3779000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1452000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2327000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.143 pure
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
9000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
14000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
11000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
14000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4657635
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3979000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
535000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.48
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
232081
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.53
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
132573
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.14
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4827981
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.64
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M17D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1631000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
938138
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.41
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M8D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
675000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
628000 usd
CY2024Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2023Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
933000 usd
CY2024Q1 us-gaap Revenues
Revenues
1476000 usd
CY2023Q1 us-gaap Revenues
Revenues
711000 usd

Files In Submission

Name View Source Status
0001437749-24-029935-index-headers.html Edgar Link pending
0001437749-24-029935-index.html Edgar Link pending
0001437749-24-029935.txt Edgar Link pending
0001437749-24-029935-xbrl.zip Edgar Link pending
ex_726326.htm Edgar Link pending
ex_726327.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logor.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wrap-20240331.xsd Edgar Link pending
wrap20240331_10q.htm Edgar Link pending
wrap-20240331_cal.xml Edgar Link unprocessable
wrap-20240331_def.xml Edgar Link unprocessable
wrap-20240331_pre.xml Edgar Link unprocessable
wrap-20240331_lab.xml Edgar Link unprocessable
wrap20240331_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable